{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:00:01Z","timestamp":1765540801667,"version":"3.48.0"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Complementary and Integrative Medicine"],"abstract":"<jats:p>\n                    <jats:bold>Abstract<\/jats:bold>\n                    : This integrative literature review focused on the use of omega-3 fatty acid supplementation for the treatment of Crohn\u2019s disease (CD). A systematic review of studies investigating the use of omega-3 in individuals with CD was performed. OVID MEDLINE, the Cochrane Database, and CINAHL were searched for pertinent research. Experiments were limited to double-blind placebo controlled trials. Five studies observing CD relapse rates and three studies examining biochemical changes were evaluated. The studies reviewed show contradicting information regarding the efficacy of omega-3 for CD. While some studies have shown supplementation with omega-3 results in sustained remission from disease, other studies concluded no correlation between omega-3 supplementation and improved remission rates. Studies investigating biochemical variables suggest favorable changes in immunological milieu, including modifications of lipid profiles and cytokine production. The studies reviewed are adversely limited by low number of participants, short duration of study and other significant deficits. Limited data remain available and current literature indicated mixed conclusions regarding the efficacy of omega-3 for treatment of CD. Further large-scale studies of longer duration are necessary.\n                  <\/jats:p>","DOI":"10.1515\/jcim-2012-0010","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T07:26:15Z","timestamp":1367825175000},"page":"221-228","source":"Crossref","is-referenced-by-count":7,"title":["Omega-3 fatty acid for the treatment and remission of Crohn\u2019s disease"],"prefix":"10.1515","volume":"10","author":[{"given":"Katharine","family":"Swan","sequence":"first","affiliation":[{"name":"Yale University, New Haven, CT, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat J.","family":"Allen","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, CT, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"2025121209153203784_CIT0001_w2aab3b8c38b1b7b1ab2ab1Aa","unstructured":"Crohn\u2019s and Colitis Foundation of America. About Crohn\u2019s disease, 2009. Available at: http:\/\/www.ccfa.org\/info\/about\/crohns. Accessed January2011."},{"key":"2025121209153203784_CIT0002_w2aab3b8c38b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult crohn\u2019s disease in population-based cohorts","volume":"105","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2025121209153203784_CIT0003_w2aab3b8c38b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","article-title":"Clinical implications of mucosal healing for the management of IBD","volume":"7","year":"2010","journal-title":"Nat Rev Gastroeneterol Hepatol"},{"key":"2025121209153203784_CIT0004_w2aab3b8c38b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MOG.0b013e32832c073a","article-title":"Immunosuppression in inflammatory bowel disease: Traditional, biological or both?","volume":"25","year":"2009","journal-title":"Curr Opin Gastroeneterol"},{"issue":"6","key":"2025121209153203784_CIT0005_w2aab3b8c38b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1542\/peds.2008-2173","article-title":"The use of complementary and alternative medicine in pediatrics","volume":"122","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"2025121209153203784_CIT0006_w2aab3b8c38b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctcp.2009.02.003","article-title":"Use of complementary and alternative medicine among patients with chronic disease at outpatient clinics","volume":"15","year":"2009","journal-title":"Complement Ther Clin Pract"},{"issue":"1","key":"2025121209153203784_CIT0007_w2aab3b8c38b1b7b1ab2ab7Aa","first-page":"240","article-title":"Herbal remedies and children: do they work? Are they harmful?","volume":"112","year":"2003","journal-title":"Pediatrics"},{"key":"2025121209153203784_CIT0008_w2aab3b8c38b1b7b1ab2ab8Aa","unstructured":"National Center for Complementary and Alternative Medicine (NCCAM). The use of complementary and alternative medicine in the United States, 2008. Available at: http:\/\/nccam.nih.gov\/news\/camstats\/2007\/camsurvey_fs1.htm. Accessed October2010."},{"issue":"4","key":"2025121209153203784_CIT0009_w2aab3b8c38b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00001610-200607000-00005","article-title":"Omega-3 fatty acids as adjunctive therapy in Crohns disease","volume":"29","year":"2006","journal-title":"Gastroenterol Nurs"},{"key":"2025121209153203784_CIT0010_w2aab3b8c38b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2174\/138161209789909746","article-title":"Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis","volume":"15","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"8","key":"2025121209153203784_CIT0011_w2aab3b8c38b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/art.1780380813","article-title":"Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs clinical and immune correlates","volume":"38","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025121209153203784_CIT0012_w2aab3b8c38b1b7b1ab2ac12Aa","first-page":"885","article-title":"Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases","volume":"52","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"2025121209153203784_CIT0013_w2aab3b8c38b1b7b1ab2ac13Aa","first-page":"1","article-title":"Omega 3 fatty acids (fish oil) for maintenance of remission in crohn\u2019s disease","volume":"1","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"2025121209153203784_CIT0014_w2aab3b8c38b1b7b1ab2ac14Aa","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199606133342401","article-title":"Effect of an enteric-coated fish-oil preparation on relapses in Crohn\u2019s disease","volume":"334","year":"1996","journal-title":"N Eng J Med"},{"issue":"3","key":"2025121209153203784_CIT0015_w2aab3b8c38b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index: national cooperative Crohn\u2019s disease study","volume":"70","year":"1976","journal-title":"Gastroenterology"},{"issue":"8","key":"2025121209153203784_CIT0016_w2aab3b8c38b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3109\/00365529609010352","article-title":"Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn\u2019s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn\u2019s Disease Study Group)","volume":"31","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"2025121209153203784_CIT0017_w2aab3b8c38b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.3748\/wjg.v11.i45.7118","article-title":"Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn\u2019s disease: a double-blind, randomized, placebo-controlled study","volume":"11","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2025121209153203784_CIT0018_w2aab3b8c38b1b7b1ab2ac18Aa","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.299.14.1690","article-title":"Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials","volume":"299","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"2025121209153203784_CIT0019_w2aab3b8c38b1b7b1ab2ac19Aa","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00054725-200005000-00002","article-title":"Nutritional supplementation with N-3 fatty acids and antioxidants in individuals with Crohn\u2019s disease in remission: effects on antioxidant status and fatty acid profile","volume":"6","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"2025121209153203784_CIT0020_w2aab3b8c38b1b7b1ab2ac20Aa","first-page":"11","article-title":"Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in individuals with active Crohn\u2019s disease compared with omega-6 fatty acids","volume":"22","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121209153203784_CIT0021_w2aab3b8c38b1b7b1ab2ac21Aa","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ajcn\/80.5.1137","article-title":"Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease","volume":"80","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"2025121209153203784_CIT0022_w2aab3b8c38b1b7b1ab2ac22Aa","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM198505093121902","article-title":"Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglycerinemia","volume":"312","year":"1985","journal-title":"N Eng J Med"},{"issue":"6","key":"2025121209153203784_CIT0023_w2aab3b8c38b1b7b1ab2ac23Aa","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1592\/phco.29.6.680","article-title":"Optimizing pediatric dosing: a developmental pharmacologic approach","volume":"29","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2025121209153203784_CIT0024_w2aab3b8c38b1b7b1ab2ac24Aa","first-page":"3","article-title":"The relationship between the fatty acid composition of immune cells and their function","volume":"79","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2025121209153203784_CIT0025_w2aab3b8c38b1b7b1ab2ac25Aa","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.prostaglandins.2009.03.002","article-title":"Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1","volume":"89","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"2025121209153203784_CIT0026_w2aab3b8c38b1b7b1ab2ac26Aa","first-page":"59","article-title":"Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oil","volume":"56","year":"2010","journal-title":"Cell Mol Biol"},{"key":"2025121209153203784_CIT0027_w2aab3b8c38b1b7b1ab2ac27Aa","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gut.2007.134817","article-title":"Predicting relapse in Crohn\u2019s disease: a biopsychosocial model","volume":"57","year":"2008","journal-title":"Gut"}],"container-title":["jcim"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0010\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:54:59Z","timestamp":1765540499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0010\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,6,15]]}},"alternative-id":["10.1515\/jcim-2012-0010"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2012-0010","relation":{},"ISSN":["1553-3840","2194-6329"],"issn-type":[{"type":"electronic","value":"1553-3840"},{"type":"print","value":"2194-6329"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}